Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report

F. Willermain, Kathrin Greiner, John Vincent Forrester

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: To describe a case of severe central retinal vein occlusion (CRVO) in a young patient, in whom intensive immunosuppressive therapy improved the clinical outcome. Case report: A 35-year-old men presented with a first episode of CRVO in his right eye in 1990. Despite corticosteroids, and laser treatment, rubeotic glaucoma developed and the eye had to be enucleated. Seven years later, CRVO developed in the fellow eye, with venous tortuosity and haemorrhages. An extensive systemic workup was unremarkable. Corticosteroids failed to control the clinical situation. Cells were seen in the anterior vitreous. Visual acuity decreased to 2/60. Cyclosporine and azathioprine were added, but did not prevent recurrences. Campath-1H treatment was then started and visual acuity improved to 6/36. In November 2000, visual acuity was 6/24 and haemorrhages had cleared. Discussion: Many authors have proposed a role for inflammation in the pathophysiology of CRVO in young patients. However, there is no general agreement on corticosteroid use in these patients. Our case illustrates that, in some settings, high-dose corticosteroids and intensive immunosuppression might be used successfully to preserve vision.

Original languageEnglish
Pages (from-to)141-145
Number of pages4
JournalOcular Immunology and Inflammation
Volume10
Issue number2
DOIs
Publication statusPublished - 2002

Keywords

  • CRVO
  • young adults
  • vasculitis
  • immunosuppression
  • CAMPATH-1H

Cite this

Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report. / Willermain, F.; Greiner, Kathrin; Forrester, John Vincent.

In: Ocular Immunology and Inflammation, Vol. 10, No. 2, 2002, p. 141-145.

Research output: Contribution to journalArticle

Willermain, F. ; Greiner, Kathrin ; Forrester, John Vincent. / Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report. In: Ocular Immunology and Inflammation. 2002 ; Vol. 10, No. 2. pp. 141-145.
@article{da710690e1c848329b35a48ea058a1fb,
title = "Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report",
abstract = "Purpose: To describe a case of severe central retinal vein occlusion (CRVO) in a young patient, in whom intensive immunosuppressive therapy improved the clinical outcome. Case report: A 35-year-old men presented with a first episode of CRVO in his right eye in 1990. Despite corticosteroids, and laser treatment, rubeotic glaucoma developed and the eye had to be enucleated. Seven years later, CRVO developed in the fellow eye, with venous tortuosity and haemorrhages. An extensive systemic workup was unremarkable. Corticosteroids failed to control the clinical situation. Cells were seen in the anterior vitreous. Visual acuity decreased to 2/60. Cyclosporine and azathioprine were added, but did not prevent recurrences. Campath-1H treatment was then started and visual acuity improved to 6/36. In November 2000, visual acuity was 6/24 and haemorrhages had cleared. Discussion: Many authors have proposed a role for inflammation in the pathophysiology of CRVO in young patients. However, there is no general agreement on corticosteroid use in these patients. Our case illustrates that, in some settings, high-dose corticosteroids and intensive immunosuppression might be used successfully to preserve vision.",
keywords = "CRVO, young adults, vasculitis, immunosuppression, CAMPATH-1H",
author = "F. Willermain and Kathrin Greiner and Forrester, {John Vincent}",
year = "2002",
doi = "10.1076/ocii.10.2.141.13981",
language = "English",
volume = "10",
pages = "141--145",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report

AU - Willermain, F.

AU - Greiner, Kathrin

AU - Forrester, John Vincent

PY - 2002

Y1 - 2002

N2 - Purpose: To describe a case of severe central retinal vein occlusion (CRVO) in a young patient, in whom intensive immunosuppressive therapy improved the clinical outcome. Case report: A 35-year-old men presented with a first episode of CRVO in his right eye in 1990. Despite corticosteroids, and laser treatment, rubeotic glaucoma developed and the eye had to be enucleated. Seven years later, CRVO developed in the fellow eye, with venous tortuosity and haemorrhages. An extensive systemic workup was unremarkable. Corticosteroids failed to control the clinical situation. Cells were seen in the anterior vitreous. Visual acuity decreased to 2/60. Cyclosporine and azathioprine were added, but did not prevent recurrences. Campath-1H treatment was then started and visual acuity improved to 6/36. In November 2000, visual acuity was 6/24 and haemorrhages had cleared. Discussion: Many authors have proposed a role for inflammation in the pathophysiology of CRVO in young patients. However, there is no general agreement on corticosteroid use in these patients. Our case illustrates that, in some settings, high-dose corticosteroids and intensive immunosuppression might be used successfully to preserve vision.

AB - Purpose: To describe a case of severe central retinal vein occlusion (CRVO) in a young patient, in whom intensive immunosuppressive therapy improved the clinical outcome. Case report: A 35-year-old men presented with a first episode of CRVO in his right eye in 1990. Despite corticosteroids, and laser treatment, rubeotic glaucoma developed and the eye had to be enucleated. Seven years later, CRVO developed in the fellow eye, with venous tortuosity and haemorrhages. An extensive systemic workup was unremarkable. Corticosteroids failed to control the clinical situation. Cells were seen in the anterior vitreous. Visual acuity decreased to 2/60. Cyclosporine and azathioprine were added, but did not prevent recurrences. Campath-1H treatment was then started and visual acuity improved to 6/36. In November 2000, visual acuity was 6/24 and haemorrhages had cleared. Discussion: Many authors have proposed a role for inflammation in the pathophysiology of CRVO in young patients. However, there is no general agreement on corticosteroid use in these patients. Our case illustrates that, in some settings, high-dose corticosteroids and intensive immunosuppression might be used successfully to preserve vision.

KW - CRVO

KW - young adults

KW - vasculitis

KW - immunosuppression

KW - CAMPATH-1H

U2 - 10.1076/ocii.10.2.141.13981

DO - 10.1076/ocii.10.2.141.13981

M3 - Article

VL - 10

SP - 141

EP - 145

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 2

ER -